Based on the Lyxor MDAX® (DR) UCITS ETF stock forecast from 0 analysts, the average analyst target price for Lyxor MDAX® (DR) UCITS ETF is not available over the next 12 months. Lyxor MDAX® (DR) UCITS ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Lyxor MDAX® (DR) UCITS ETF is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Lyxor MDAX® (DR) UCITS ETF’s stock price was EUR 24.19. Lyxor MDAX® (DR) UCITS ETF’s stock price has changed by +2.07% over the past week, 0% over the past month and +7.11% over the last year.
No recent analyst target price found for Lyxor MDAX® (DR) UCITS ETF
No recent average analyst rating found for Lyxor MDAX® (DR) UCITS ETF
Stock Target Advisor's fundamental analysis for Lyxor MDAX® (DR) UCITS ETF's stock is Very Bearish.
C007:F stock's dividend yield is 3.44%.
Our analysis grades C007:F stock's dividend yield at F. This means that C007:F stock's dividend yield is above 47% of the stocks in the Others sector in the F exchange.
Based on this C007:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on C007:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on C007:F's stock to indicate if its overvalued.
The last closing price of C007:F's stock was EUR 24.19.
The most recent market capitalization for C007:F is EUR 0.18B.
Unfortunately we do not have enough analyst data on C007:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Lyxor MDAX® (DR) UCITS ETF's stock.
Sorry, we do not have any data on the number of employees for Lyxor MDAX® (DR) UCITS ETF.
Sorry we do not have any infomation available on Lyxor MDAX® (DR) UCITS ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Stock Target Advisor's fundamental analysis for Lyxor MDAX® (DR) UCITS ETF's stock is Very Bearish.
C007:F stock's dividend yield is 3.44%.
Our analysis grades C007:F stock's dividend yield at F. This means that C007:F stock's dividend yield is above 47% of the stocks in the Others sector in the F exchange.
Based on this C007:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on C007:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on C007:F's stock to indicate if its overvalued.
The last closing price of C007:F's stock was EUR 24.19.
The most recent market capitalization for C007:F is EUR 0.18B.
Unfortunately we do not have enough analyst data on C007:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Lyxor MDAX® (DR) UCITS ETF's stock.
Sorry, we do not have any data on the number of employees for Lyxor MDAX® (DR) UCITS ETF.
Sorry we do not have any infomation available on Lyxor MDAX® (DR) UCITS ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for C007:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
